2009 ACR/ARHP Annual Scientific Meeting: Keyword Index A

abatacept

638Disease Remission Is Achieved within Two Years in Over Half of Methotrexate Naive Patients with Early Erosive Rheumatoid Arthritis (RA) Treated with Abatacept Plus MTX: Results From the AGREE Trial

639Reduced Radiographic Progression in Patients with Early Rheumatoid Arthritis (RA) Treated with Abatacept + Methotrexate Compared to Methotrexate Alone: 24 Month Outcomes

1260Abatacept in Psoriatic Arthritis: Results of a Phase II Study

2052Abatacept IN Refractory ANTI-TNF Resistant Juvenile Idiopathic ARTHRITIS-RELATED Uveitis

access to care

1937Disparities in Post-Acute Rehabilitation Care for Joint Replacement

activities of daily living (ADL)

1856Problems and Coping Strategies Reported by Computer Users with RA

activity score

1245Patient's Global Assessment of Disease Activity and Patient's Assessment of General Health in Rheumatoid Arthritis: Are They Equivalent?

1998Objective Disease Activity Assessment for Rheumatoid Arthritis Using Optical Monitoring

adalimumab

1187The Efficacy and Safety of Caudal Epidural Injection with the TNF Antagonist, Adalimumab and Eternacept, in Patients with Disc-Herniation-Induced Sciatica. RESULTS of A RANDOMIZED, CONTROLLED , 1-Month Follow-up Study

adhesion molecules

1155Soluble Junctional Adhesion Molecule-C Promotes Mononuclear Cell Recruitment in Rheumatoid Arthritis

adolescent patients

1898Juvenile Dermatomyositis: A Novel Gingival Vessel Alteration Pattern?

anakinra

589Anakinra in Patients with Refractory Idiopathic Inflammatory Myopathies

ANCA

550Rituximab Versus Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitis: A Randomized Controlled Trial (RAVE)

644A Cross Sectional Study Comparing the CDA to the VDI for the Assessment of Damage in Vasculitis

645Risk of Malignancy in Patients Treated for ANCA-Associated Vasculitides: Follow-up Data From Clinical Trials of the European Vasculitis Study Group (EUVAS)

647Comparison of Disease Manifestations of ANCA-Associated Vasculitis Based On ANCA Type Among Participants in a Multicenter Clinical Trial

648The Value of Rise in Anti-Neutrophil Cytoplasmic Antibody (ANCA) Measurements for Predicting Relapse Among Patients with ANCA-Associated Vasculitis - A Meta-Analysis

angiogenesis

1154IL-17 Upregulates Expression of Proangiogenic Mediators, and Vascularity Is Elevated in the IL-17-Induced Arthritis Model

1157IL-17A Upregulates Angiogenesis, Cytoskeletal Rearrangement and Cell Migration in a Chemokine Dependent Manner

1158Alterations in the Hypoxic Joint Environment and Blood Vessel Maturity Pre/Post Anti-Tnfα Therapy

2047Interaction Between Nicked β2-Glycoprotein I and Angiostatin 4.5; Novel Role of Nicked β2-Glycoprotein I in Angiogenesis in Vitro and In Vivo

animal models

552Tracking JIA Predisposition Genes From Genome-Wide Association Studies to Next Generation Sequencing to Functional Relevance

626Interaction Between ASC and Estrogen in the Regulation of Inflammation in Murine Arthritis

1212FLIP: The Master Regulator of Myeloid Differentiation and Survival, a Novel Therapeutic Target in Chronic Inflammation

1236Familial Mediterranean Fever (FMF)-Associated B30.2 (PRYSPRY) Mutations Activate a NLRP3-Independent Inflammasome and Induce Autoinflammatory Disease in Mice

1263Tyrosine Kinase Inhibitors (TKI) Are Promising Therapeutic Agents for the Proliferative Vasculopathy in SSc

1967Maintenance of T Cell Rap1 Signaling Protects Mice against Collagen-Induced Arthritis

2000Lentiviral-Based Bioluminescent Imaging of Synovial Inflammatory Subtypes in Experimental Arthritis and Human Synovial Fibroblasts

2020Epistatic Interactions Between Lupus Susceptibility Loci On New Zealand Black Chromosomes 1 and 13 Lead to Marked Expansion of Dendritic Cell Populations but Have Little Effect On Autoimmunity

2041IL-21R-Deficiency During Experimental Arthritis Increases Local Expression of Inflammatory Mediators, but Protects against Joint Pathology by Suppressing Th17 Cells

ankylosing spondylitis (AS)

1166Dysregulation of Wnt/Beta-Catenin Signaling in Ank/Ank Mice Is Associated with Hypertrophic Chondrocyte Differentiation and New Osteoid Deposition in Articular Cartilage: a Novel Insight in a Mouse Model of Joint Ankylosis

1167Genome-Wide Screening Newly Discovers That the Tnfα- and IL17- Inducible RGS1 Is the Most Highly Differentially Expressed Gene in Undifferentiated Spondyloarthritis (USpA)

1170High-Density Genome-Wide Linkage Study in Spondyloarthritis (SpA) Families Identifies Three New Significant Susceptibility Chromosomal Regions

1171HLA Class I and II Associations of Ankylosing Spondylitis

1182Comparative Study of MRI and Power Doppler Ultrasonography (US) of the Heel in Spondyloarthritis (SpA) Patients with and without Heel Pain and in Controls: The ETERS Study

1227Evidence of Genetic Overlap Between Ankylosing Spondylitis and Crohn's Disease

1231Genomewide Scan in Acute Anterior Uveitis: Similarities and Differences with Genes Associated with Ankylosing Spondylitis

antibodies

566Impact of Clinical and Demographic Features On Influenza Vaccination Responses in Human Systemic Lupus Erythematosus

584IgG Anti-NR2 Glutamate Receptor Antibodies From Patients with SLE as Causative Auto-Antibodies of Damage to the Blood-Brain Barrier

1214Antiphospholipid Antibodies Predict Future Arterial Events

2048Autoantibodies to Heat Shock Protein 60 Are Associated with Arterial Vascular Events in Patients with Anti-Phospholipid Antibodies

anticardiolipin

2050A C5a Receptor Antagonist Ameliorates In Vivo Effects of Antiphospholipid Antibodies

anti-CCP antibodies

599Prevalence and Determinants of Vitamin D Insufficiency/Deficiency in U. S. Veterans with Rheumatoid Arthritis

1161The Mechanisms Underlying Arthritogenicity of Human Anti-Citrulline Antibodies

1162Smoking and Anti-CCP Antibodies Predict Rheumatoid Arthritis

anti-citrullinated protein/peptide antibodies (ACPA)

1165The Periodontium Contains Citrullinated Proteins, PAD-2 Enzymes and HC Gp-39

antigen-presenting cells

1213Specific Targeting of TNF Receptor I in Synoviocytes or Antigen-Presenting Cells in Secondary Lymphoid Organs Ameliorates Collagen-Induced Arthritis

antinucleosome antibodies

628Regulatory Natural Antibodies to Apoptotic Cell Membrane Determinants Inhibit Pro-Inflammatory Responses to Activating IgG Autoantibody Immune Complexes Implicated in Autoimmune Pathogenesis

antioxidants

630Incidence of Severe Knee and Hip Osteoarthritis in Relation to Dietary Intake of Antioxidants Beta�Carotene, Vitamin C, Vitamin E and Selenium: a Population-Based Prospective Cohort Study

antiphospholipid syndrome

1215Association of Traditional and Novel Antiphospholipid Antibody Assays with Thrombosis in SLE

1216Antiphospholipid Score (aPL-S) in the Antiphospholipid Syndrome: Diagnostic Significance and Predictive Value for the Development of Thrombotic Events in Autoimmune Diseases

1217End-Stage Organ Damage and Mortality in Patients with Antiphospholipid Syndrome (APS): Prognostic Models for Serious Clinical Outcomes

1218Simvastatin and Hydroxychloroquine Can Prevent the Procoagulant/Thrombogenic Properties of Antiphospholipid Antibodies in Monocytes

1219Combination of Heparin and Aspirin Is Superior to Aspirin Alone in Enhancing Live Births in Patients with Recurrent Pregnancy Loss and Positive Antiphospholipid Antibodies: a Meta-Analysis of Randomized Controlled Trials and Meta-Regression

1985Cardiovascular Disease (CVD) Prevention Counseling Program for Systemic Lupus Erythematosus (SLE) and/or Antiphospholipid Antibody (aPL) Positive Patients

2045Lupus Susceptible Gene Polymorphisms in Patients with Antiphospholipid Syndrome

2048Autoantibodies to Heat Shock Protein 60 Are Associated with Arterial Vascular Events in Patients with Anti-Phospholipid Antibodies

2049�2 Glycoprotein I (�2GPI) Binds Platelet Factor 4 (PF4): Implications for the Pathogenesis of Antiphospholipid Syndrome

2050A C5a Receptor Antagonist Ameliorates In Vivo Effects of Antiphospholipid Antibodies

anti-TNF therapy

LB6In Early RA with Insufficient Response to MTX, the Addition of Anti-TNF Results in Less Radiological Progression Over 24 Months Than the Addition of Conventional DMARDs: Results From the SWEFOT Trial

573Genome-Wide Association Study of Genetic Predictors of Anti-Tumour Necrosis Factor (TNF) Treatment in Rheumatoid Arthritis (RA) Identifies Associations with Polymorphisms at Five Loci

625Correlation of Disease Activity Change Due to Anti TNF Alpha Treatment with Galactosylation Status of Serum IgG in Inflammatory Arthritis

1153Serial Re-Screening in High Risk Patients On Anti-TNF-&alpha Therapy Validate CDC Recommendations for Monitoring TB Risk

1158Alterations in the Hypoxic Joint Environment and Blood Vessel Maturity Pre/Post Anti-Tnfα Therapy

1259Golimumab, a New, Human, TNF-aantibody Administered Subcutaneously Every 4 Weeks, in Ankylosing Spondylitis (AS): 104-Week Efficacy and Safety Results of the Randomized, Placebo-Controlled GO-RAISE Study

1907Comparison of Two Interferon-Gamma Release Assays to Tuberculin Skin Testing for Latent Tuberculosis Screening in Rheumatic Patients Starting Anti-TNF Treatment

1957Safety of Rituximab in Combination with a TNF Inhibitor and Methotrexate in Patients with Active Rheumatoid Arthritis: Results From a Randomized Controlled Trial (TAME)

2022Achieving Minimal Disease Activity (MDA) Criteria with Anti-TNF Therapy in Psoriatic Arthritis Can Prevent Progressive Joint Damage

2051Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (A-CUTE-JIA): A Multicenter Randomized Clinical Trial

2059The Risk for Hospitalized and Outpatient Infections Related to Anti-TNF Therapy and Newer Biologics

2060Risk of Septic Arthritis in Patients with Rheumatoid Arthritis Treated with Anti-TNF Therapy: Results From the BSR Biologics Register (BSRBR)

2062The Influence of Anti-TNF Therapy Upon Incidence of Non-Melanoma Skin Cancer (NMSC) in Patients with Rheumatoid Arthritis (RA): Results From the BSR Biologics Register (BSRBR)

apoptosis

1161The Mechanisms Underlying Arthritogenicity of Human Anti-Citrulline Antibodies

1962Role of the Urokinase Plasminogen Activator Receptor in Mediating Impaired Apoptotic Cardiocyte Clearance by Anti-SSA/Ro-SSB/La Antibodies in the Pathogenesis of Congenital Heart Block

APRIL

1986The Importance of APRIL in SLE Disease Activity and Treatment

arthrocentesis

1220Training, Practice and Assessment of Arthrocentesis Procedure Skills without Risk to a Patient

arthroplasty

1137Describing �Usual� Physical Therapy Practice Following Total Knee Replacement in Montgomery County, Pennsylvania

1937Disparities in Post-Acute Rehabilitation Care for Joint Replacement

arthroscopy

1936Factors Associated with Refusal to Participate in a Randomized Controlled Trial of Surgery Vs Non-Operative Therapy for Meniscal Tear in Knee Osteoarthritis

Asian-Americans

1860LANtern (Lupus Asian Network): Evaluation of An Innovative National Program

assessment

1224An Instrument to Provide Documentation (iPROD) of Practice-Based Learning and Improvement (PBLI): A Pilot Trial Conducted by the Carolinas Fellows Collaborative

1866The Arthritis Educational Needs Assessment Tool: Will It Work in the Community?

1920RAPID3 and Component Measures Are as Likely as a DAS28 and Component Measures to Identify Patients with Rheumatoid Arthritis (RA) Who Have Moderate/High Disease Activity Versus Low Activity at Presentation

atherosclerosis

561A Randomised Controlled Trial of Mycophenolate Mofetil Versus Placebo On Surrogate Markers of Atherosclerosis in Systemic Lupus Erythematosus

582Type I Interferon Gene Signatures Are Associated with Vascular Risk and Atherosclerosis in Systemic Lupus Erythematosus

601Discordance in the Association of Carotid with Coronary Atherosclerosis in Rheumatoid Arthritis Compared with Controls

1928Effect of Rosuvastatin On Homocysteine, hsCRP and Endothelial Markers in Systemic Lupus Erythematosus (SLE): a Randomized Controlled Trial

1929Pihdl Is Associated with a 19- Fold Increased Risk of Progression of Subclinical Atherosclerosis in SLE

1984Depression Is a Risk Factor for Subclinical Atherosclerosis in SLE

2044Pathogenic Role of IL-17 in Atherogenesis: A Cross Link Between Rheumatoid Arthritis and Atherosclerosis

autoantibodies

580Vitamin D Deficiency Is Associated with B Cell Hyperreactivity in Systemic Lupus Erythematosus

642Novel Proteasome Inhibitors Have a Beneficial Effect in Murine Lupus

1151A Novel Autoantibody against 200/100 Kd Proteins Is Associated with Necrotizing Myopathy

1251Preventive IVIG Therapy for Congenital Heart Block (PITCH)

1908Autoantibodies to miRNA-Binding Protein Argonaute 2 (Su antigen) in Patients with Hepatitis C Virus Infection

1965The Immune Response to Citrullinated Peptides in the Pathogenesis of Rheumatoid Arthritis

1987Reactivity with Dichotomous Determinants of Ro60 Stratifies Autoantibody Responses in Lupus and Primary Sjogren's Syndrome

1988Pituitary Tumor-Transforming 1 Interacting Protein (PTTG1IP) Is a Novel Target for Autoantibodies in RA

autoimmune diseases

619Putative Autoimmune Susceptibility Loci; TENR-IL2-IL21, AFF3 and CTLA4, Are Associated with Juvenile Idiopathic Arthritis

1243IL-17 Acts through Act1 and TRAF6 to Mediate the Canonical NF-κB Signaling Pathway to Upregulate RGS16 Expression in Autoimmune B Cells of BXD2 Mice

1896All-Trans Retinoic Acid Promotes the Differentiation of Itreg Cells Via Smad and Non-Smad Signaling Pathways

1927CH-1504, a Metabolically Inert Antifolate, Is An Effective and Well-Tolerated Treatment for Patients with Moderate to Severe Rheumatoid Arthritis

1964TL1A-DR3 Interactions: An Attractive Target for Immunotherapy

2015Anti-PD-1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice

2055Evaluation of Safety and Preliminary Efficacy of Canakinumab (ACZ885), a New IL-1-Beta Blocking Monoclonal Antibody, in Children with Systemic Juvenile Idiopathic Arthritis (sJIA)

Keyword Index: A